Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 15, Number 7—July 2009

Dispatch

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

Shmuel Stienlauf1Comments to Author , Vered Yahalom1, Eli Schwartz, Eilat Shinar, Gad Segal, and Yechezkel Sidi
Author affiliations: Sheba Medical Center, Tel Hashomer, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Tel Aviv University, Tel Aviv, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Magen David Adom National Blood Services, Ramat Gan, Israel (V. Yahalom, E. Shinar).; 1These authors contributed equally to this article.

Main Article

Figure 2

Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.

Figure 2. . Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.

Main Article

1These authors contributed equally to this article.

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO